THYCONVI DIN 02568373
Health Canada record
| Active ingredient(s) | LEVOTHYROXINE SODIUM 20 MCG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H03AA01 LEVOTHYROXINE SODIUM |
| Original market date | 25-May-2026 |
| Current status date | 25-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
BioSyent Pharma Inc. — licence 101634, currently licensed, last inspection rating C (2024-07-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVOTHYROXINE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02550806 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 200 MCG | Marketed |
| 02550792 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 175 MCG | Marketed |
| 02550784 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 150 MCG | Marketed |
| 02550709 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 25 MCG | Marketed |
| 02534681 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 100 MCG | Marketed |
| 02550776 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 137 MCG | Marketed |
| 02550768 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 125 MCG | Marketed |
| 02550741 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 112 MCG | Marketed |
| 02550733 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 88 MCG | Marketed |
| 02550725 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 75 MCG | Marketed |
| 02550717 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 50 MCG | Marketed |
| 02534703 | APO-LEVOTHYROXINE | APOTEX INC | Tablet | LEVOTHYROXINE SODIUM 300 MCG | Marketed |
| 02559927 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 75 MCG | Approved |
| 02213192 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 50 MCG | Marketed |
| 02213206 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 100 MCG | Marketed |
| 02213214 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 150 MCG | Marketed |
| 02213222 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 200 MCG | Marketed |
| 02559978 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 137 MCG | Approved |
| 02559935 | ELTROXIN | ASPEN PHARMACARE CANADA INC. | Tablet | LEVOTHYROXINE SODIUM 88 MCG | Approved |
| 02461722 | LEVOTHYROXINE SODIUM FOR INJECTION | AVIR PHARMA INC. | Powder For Solution | LEVOTHYROXINE SODIUM 500 MCG | Marketed |
| 02245948 | LEVOTHYROXINE SODIUM FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | LEVOTHYROXINE SODIUM 500 MCG | Marketed |
| 02461714 | LEVOTHYROXINE SODIUM FOR INJECTION | AVIR PHARMA INC. | Powder For Solution | LEVOTHYROXINE SODIUM 200 MCG | Marketed |
| 02499924 | LEVOTHYROXINE SODIUM INJECTION | FRESENIUS KABI CANADA LTD | Solution | LEVOTHYROXINE SODIUM 100 MCG | Marketed |
| 02499916 | LEVOTHYROXINE SODIUM INJECTION | FRESENIUS KABI CANADA LTD | Solution | LEVOTHYROXINE SODIUM 40 MCG | Marketed |
| 02172127 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 150 MCG | Marketed |
| 02172119 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 125 MCG | Marketed |
| 02172100 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 100 MCG | Marketed |
| 02172097 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 88 MCG | Marketed |
| 02172089 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 75 MCG | Marketed |
| 02172070 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 50 MCG | Marketed |
| 02171228 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 112 MCG | Marketed |
| 02172143 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 200 MCG | Marketed |
| 02233852 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 137 MCG | Marketed |
| 02172062 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 25 MCG | Marketed |
| 02172151 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 300 MCG | Marketed |
| 02172135 | SYNTHROID | BGP PHARMA ULC | Tablet | LEVOTHYROXINE SODIUM 175 MCG | Marketed |
| 02264323 | EUTHYROX | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | LEVOTHYROXINE SODIUM 25 MCG | Cancelled Post Market |
| 02264374 | EUTHYROX | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | LEVOTHYROXINE SODIUM 100 MCG | Cancelled Post Market |
| 02264390 | EUTHYROX | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | LEVOTHYROXINE SODIUM 112 MCG | Cancelled Post Market |
| 02264420 | EUTHYROX | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | LEVOTHYROXINE SODIUM 150 MCG | Cancelled Post Market |
| 02264439 | EUTHYROX | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | LEVOTHYROXINE SODIUM 175 MCG | Cancelled Post Market |
| 02264455 | EUTHYROX | EMD SERONO, A DIVISION OF EMD INC., CANADA | Tablet | LEVOTHYROXINE SODIUM 300 MCG | Cancelled Post Market |
| 02429438 | LEVENTA | INTERVET CANADA CORP | Solution | LEVOTHYROXINE SODIUM 1 MG | Cancelled Post Market |
| 02237217 | LEVOTEC 112MCG TABLETS USP | TECHNILAB PHARMA INC. | Tablet | LEVOTHYROXINE SODIUM 112 MCG | Cancelled Post Market |
| 02237220 | LEVOTEC 175MCG TABLETS USP | TECHNILAB PHARMA INC. | Tablet | LEVOTHYROXINE SODIUM 175 MCG | Cancelled Post Market |
| 02237213 | LEVOTEC 25MCG TABLETS USP | TECHNILAB PHARMA INC. | Tablet | LEVOTHYROXINE SODIUM 25 MCG | Cancelled Post Market |
| 02238435 | NV-THYRO | NOVOPHARM LIMITED | Tablet | LEVOTHYROXINE SODIUM 0.7 MG | Cancelled Post Market |
| 02238433 | NV-THYRO | NOVOPHARM LIMITED | Tablet | LEVOTHYROXINE SODIUM 0.5 MG | Cancelled Post Market |
| 01953591 | PMS-LEVOTHYROXINE SODIUM TAB 25MCG | PHARMASCIENCE INC | Tablet | LEVOTHYROXINE SODIUM 25 MCG | Cancelled Post Market |
| 01953613 | PMS-LEVOTHYROXINE SODIUM TAB 75MCG | PHARMASCIENCE INC | Tablet | LEVOTHYROXINE SODIUM 75 MCG | Cancelled Post Market |
| 02532808 | THYROKARE | NEOGEN CORPORATION | Tablet | LEVOTHYROXINE SODIUM 0.6 MG | Cancelled Pre Market |
| 02532832 | THYROKARE | NEOGEN CORPORATION | Tablet | LEVOTHYROXINE SODIUM 1 MG | Cancelled Pre Market |
| 02508494 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 25 MCG | Cancelled Pre Market |
| 02508508 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 50 MCG | Cancelled Pre Market |
| 02508516 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 75 MCG | Cancelled Pre Market |
| 02508524 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 88 MCG | Cancelled Pre Market |
| 02508540 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 112 MCG | Cancelled Pre Market |
| 02508575 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 150 MCG | Cancelled Pre Market |
| 02508583 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 175 MCG | Cancelled Pre Market |
| 02508486 | TIROCAP | IBSA INSTITUT BIOCHIMIQUE SA | Capsule | LEVOTHYROXINE SODIUM 13 MCG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37564 | 2026-05-15 | New Drug Submission (NDS) |
International API supply for LEVOTHYROXINE SODIUM
11 active FDA Drug Master Files.
Request a quote for THYCONVI